To buy shares in Bio-Path Holdings Inc. you will need a US based stock trading platform like Interactive Brokers, eToro or Moomoo where it currently costs $0.21 to buy one share in Bio-Path Holdings Inc. (as of 16:00 18-Feb-2025). Which is a change of $0.42 or -66.84% from the last closing price of $0.21.
How To Buy Bio-Path Holdings Inc. Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Bio-Path Holdings Inc.:
- Pick a stock broker (jump down to compare the best brokers for buying Bio-Path Holdings Inc. stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:BPTH)
- Choose the number of shares you want to buy (1 share currently costs $0.21)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your Bio-Path Holdings Inc. stock in your account (this will show your profit and loss)
- Bio-Path Holdings Inc. is currently worth $1,412,360 based on the last closing price of $0.21 with 6,930,475 shares traded.
- The most recent Bio-Path Holdings Inc. daily high has been $0.36 and daily low $0.2.
- The Bio-Path Holdings Inc. stock price 52 week high has been $9.83 and the 52 week low $0.59.
Compare Brokers For Buying Bio-Path Holdings Inc. Stock
Is Now A Good Time To Buy Bio-Path Holdings Inc. Stock?
- Bio-Path Holdings Inc.’s EPS (earnings per share) are -12.25. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Bio-Path Holdings Inc.’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Bio-Path Holdings Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.